Perspective Therapeutics (CATX) Gross Margin Growth (3y) (2013 - 2023)
Perspective Therapeutics (CATX) Gross Margin Growth (3y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | -324.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -164.00 |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 56.00 |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 311.00 |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -2,887.00 |
| Sep 30, 2023 | -1,849.00 |
| Jun 30, 2023 | -3,046.00 |
| Mar 31, 2023 | -3,563.00 |
| Sep 30, 2022 | -1,440.00 |
| Jun 30, 2022 | -197.00 |
| Mar 31, 2022 | 383.00 |
| Dec 31, 2021 | 315.00 |
| Sep 30, 2021 | 659.00 |
| Jun 30, 2021 | 2,203.00 |
| Mar 31, 2021 | 1,367.00 |
| Dec 31, 2020 | 1,490.00 |
| Sep 30, 2020 | 3,038.00 |
| Jun 30, 2020 | 1,064.00 |
| Mar 31, 2020 | 3,638.00 |
| Dec 31, 2019 | 5,046.00 |
| Sep 30, 2019 | 4,895.00 |
| Jun 30, 2019 | 4,997.00 |
| Mar 31, 2019 | 4,018.00 |
| Dec 31, 2018 | 3,766.00 |